Nabla Bio, a small startup founded by scientists from geneticist George Church’s lab at Harvard Medical School, has formed drug discovery collaborations with AstraZeneca, Bristol Myers Squibb and Takeda, the company told Endpoints News in an exclusive interview.
The startup is based on large language models developed in…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
